Halozyme Therapeutics shares owned by Paradigm Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Paradigm Capital Management
from 13F filings
Historical chart of Paradigm Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Paradigm Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Paradigm Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2013-03-31 | $58k | 10k | 5.80 |
2012-12-31 | $67k | 10k | 6.70 |
2012-09-30 | $75k | 10k | 7.50 |
2012-06-30 | $89k | 10k | 8.90 |
2012-03-31 | $128k | 10k | 12.80 |
2011-12-31 | $95k | 10k | 9.50 |
2011-09-30 | $61k | 10k | 6.10 |
2011-06-30 | $69k | 10k | 6.90 |
2011-03-31 | $67k | 10k | 6.70 |
2010-12-31 | $79k | 10k | 7.90 |
More positions owned by Paradigm Capital Management
View all positions for Paradigm Capital Management